Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CLONAZEPAM 2 MG ODT

CLONAZEPAM
$0.8815per EA
DEA Schedule CIV

Strength

2 mg/1

Manufacturer

Alembic Pharmaceuticals Inc.

NDC

62332036806

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CLONAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA211033

On Market Since

7/1/2019

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price History

1W

0.0%

1M

-1.2%

3M

-6.4%

6M

-13.0%

1Y

-4.7%

3Y

-29.7%

5Y

-30.3%

All

-12.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

CLONAZEPAM 0.5 MG TABLET
Generic
00093083201•Teva Pharmaceuticals USA Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
00093083205•Teva Pharmaceuticals USA Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
00904722761•Major Pharmaceuticals
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
16729013600•Accord Healthcare Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
16729013616•Accord Healthcare Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040610•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040611•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040650•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
50268017315•AvPAK
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
59651072201•Aurobindo Pharma Limited
$0.0200
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy